Literature DB >> 11479493

A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery.

L D Thompson1, D B McElhinney, P Findlay, W Miller-Hance, M J Chen, M Minami, E Petrossian, A J Parry, V M Reddy, F L Hanley.   

Abstract

BACKGROUND: Modified ultrafiltration has been touted as superior to conventional ultrafiltration for attenuating the consequences of hemodilution after cardiac surgery with cardiopulmonary bypass in children. We conducted a prospective randomized study to test the hypothesis that modified and conventional ultrafiltration have similar clinical effects when a standardized volume of fluid is removed.
METHODS: From October 1998 to September 1999, 110 children weighing 15 kg or less (median weight 6.1 kg, median age 6.3 months) undergoing surgery with cardiopulmonary bypass for functionally biventricular congenital heart disease were randomized to conventional (n = 67) or arteriovenous modified ultrafiltration (n = 43) for hemoconcentration. The volume of fluid removed with both methods was standardized as a percentage of effective fluid balance (the sum of prime volume and volume added during cardiopulmonary bypass minus urine output): in patients weighing less than 10 kg, 50% of effective fluid balance was removed, whereas 60% was removed in patients weighing 10 to 15 kg. Hematocrit, hemodynamics, ventricular function, transfusion of blood products, and postoperative resource use were compared between groups.
RESULTS: There were no significant differences between groups in age, weight, or duration of cardiopulmonary bypass. The total volume of fluid added in the prime and during bypass was greater in patients undergoing conventional ultrafiltration than in those receiving modified ultrafiltration (205 +/- 123 vs 162 +/- 74 mL/kg; P =.05), although the difference was due primarily to a greater indexed priming volume in patients having conventional ultrafiltration. There was no difference in the percentage of effective fluid balance that was removed in the 2 groups. Accordingly, the volume of ultrafiltrate was greater in patients receiving conventional than modified ultrafiltration (95 +/- 63 vs 68 +/- 28 mL/kg; P =.01). Preoperative and postoperative hematocrit levels were 35.6% +/- 6.6% and 36.3% +/- 5.6% in patients having conventional ultrafiltration and 34.4% +/- 6.7% and 38.7% +/- 7.5% in those having modified ultrafiltration. By repeated-measures analysis of variance, patients receiving modified and conventional ultrafiltration did not differ with respect to hematocrit value (P =.87), mean arterial pressure (P =.85), heart rate (P =.43), or left ventricular shortening fraction (P =.21) from baseline to the postbypass measurements. There were no differences between groups in duration of mechanical ventilation, stay in the intensive care unit, or hospitalization.
CONCLUSIONS: When a standardized volume of fluid is removed, hematocrit, hemodynamics, ventricular function, requirement for blood products, and postoperative resource use do not differ between pediatric patients receiving conventional and modified ultrafiltration for hemoconcentration after cardiac surgery.

Entities:  

Mesh:

Year:  2001        PMID: 11479493     DOI: 10.1067/mtc.2001.114937

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Effects of conventional ultrafiltration on renal performance during adult cardiopulmonary bypass procedures.

Authors:  Rick A Kuntz; David W Holt; Scott Turner; Lee Stichka; Bryan Thacker
Journal:  J Extra Corpor Technol       Date:  2006-06

2.  Perfusionist strategies for blood conservation in pediatric cardiac surgery.

Authors:  Yves Durandy
Journal:  World J Cardiol       Date:  2010-02-26

3.  Plasma angiopoietin-2 levels increase in children following cardiopulmonary bypass.

Authors:  John S Giuliano; Patrick M Lahni; Michael T Bigham; Peter B Manning; David P Nelson; Hector R Wong; Derek S Wheeler
Journal:  Intensive Care Med       Date:  2008-05-31       Impact factor: 17.440

4.  Fentanyl plasma levels after modified ultrafiltration in infant heart surgery.

Authors:  Andreas H Taenzer; Robert Groom; Reed D Quinn
Journal:  J Extra Corpor Technol       Date:  2005-12

5.  Consensus Report on Patient Blood Management in Cardiac Surgery by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Cardiology (TSC), and Society of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care (SCTAIC).

Authors:  Serkan Ertugay; Türkan Kudsioğlu; Taner Şen
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-10-23       Impact factor: 0.332

Review 6.  Modified ultrafiltration during cardiopulmonary bypass and postoperative course of pediatric cardiac surgery.

Authors:  Mohsen Ziyaeifard; Azin Alizadehasl; Gholamreza Massoumi
Journal:  Res Cardiovasc Med       Date:  2014-04-01

7.  The effect of combined conventional and modified ultrafiltration on mechanical ventilation and hemodynamic changes in congenital heart surgery.

Authors:  Mohsen Ziyaeifard; Azin Alizadehasl; Nahid Aghdaii; Poupak Rahimzadeh; Gholamreza Masoumi; Samad Ej Golzari; Mostafa Fatahi; Farhad Gorjipur
Journal:  J Res Med Sci       Date:  2016-11-07       Impact factor: 1.852

8.  Reevaluating the Importance of Modified Ultrafiltration in Contemporary Pediatric Cardiac Surgery.

Authors:  Vladimir Milovanovic; Dejan Bisenic; Branko Mimic; Bilal Ali; Massimiliano Cantinotti; Ivan Soldatovic; Irena Vulicevic; Bruno Murzi; Slobodan Ilic
Journal:  J Clin Med       Date:  2018-12-01       Impact factor: 4.241

9.  Modified ultrafiltration reduces postoperative blood loss and transfusions in adult cardiac surgery: a meta-analysis of randomized controlled trials.

Authors:  Zhao Kai Low; Fei Gao; Kenny Yoong Kong Sin; Kok Hooi Yap
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-10

10.  Limitations of early serum creatinine variations for the assessment of kidney injury in neonates and infants with cardiac surgery.

Authors:  Mirela Bojan; Vanessa Lopez-Lopez; Philippe Pouard; Bruno Falissard; Didier Journois
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.